Loss of appetite and weight loss
A reduced appetite and unintended weight loss can be linked to a range of health issues. It’s important to speak with a healthcare professional if you notice these symptoms.
When to seek medical help
If your loss of appetite and weight loss is severe, sudden, or accompanied by other concerning symptoms, seek urgent medical attention. Always consult a healthcare professional if you are concerned.
Conditions related to loss of appetite and weight loss
Cyclospora
Cyclospora is a type of parasite that can cause an intestinal infection known as cyclosporiasis. This infection is typically contracted by consuming food or water contaminated with the parasite's spores. It is often associated with fresh produce, such as berries, salad greens, and herbs, especially if they have been contaminated during growing or harvesting. Cyclospora is commonly found in tropical and subtropical regions, but cases have been reported in various parts of the world, including the UK, particularly when food is imported from affected areas. Symptoms of cyclosporiasis usually appear about one week after infection and can include watery diarrhoea, stomach cramps, nausea, fatigue, and loss of appetite. Some people may also experience weight loss and bloating. The symptoms can persist for several weeks if not treated, making it important to seek medical advice if you suspect you have been infected.
Glomerulonephritis
Glomerulonephritis refers to the damage occurring to the small filters in your kidneys, known as the glomeruli.
Idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the scarring of lung tissue, which leads to difficulties in breathing. Common symptoms include a persistent dry cough, shortness of breath, particularly during physical activity, and fatigue. As the condition advances, these symptoms can worsen, significantly affecting daily life. Treatment options for IPF primarily focus on managing symptoms and slowing disease progression. Antifibrotic medications, such as pirfenidone and nintedanib, are often prescribed to help reduce lung scarring. In addition, supportive therapies, including pulmonary rehabilitation and oxygen therapy, can enhance quality of life. In severe cases, a lung transplant may be considered. The outlook for individuals with IPF varies. While the disease can progress rapidly in some patients, others may experience a slower decline. Regular follow-ups with healthcare professionals are crucial for monitoring the condition and adjusting treatment as needed. Early diagnosis and intervention can improve outcomes and help manage symptoms effectively.